Revolution Medicines RVMD
NASDAQ RVMD
$199.86 +9.12 (+4.78%)
At close: Sep 24, 2026 · 4:00 PM EDT

Revolution Medicines (RVMD) Net Shares Issued and Repurchased (2019 - 2026)

Revolution Medicines (RVMD) posted Net Shares Issued and Repurchased of $2.0 million for Q1 2026, down 63.88% on a QoQ basis from $5.4 million in Q4 2025, and down 31.72% year-over-year from $2.9 million in Q1 2025.

Analysis

Revolution Medicines (RVMD) Net Shares Issued and Repurchased (2019 - 2026) Analysis & Trends

Revolution Medicines has reported Net Shares Issued and Repurchased for 8 years, with the latest figure at $2.0 million in Q1 2026.

  • On a quarterly basis, Net Shares Issued and Repurchased fell 31.72% year-over-year to $2.0 million in Q1 2026; TTM through Mar 2026 was $2.0 million, a 31.72% decrease from a year earlier, with the FY2025 full-year figure at $5.4 million, up 29.58% from the prior year.
  • Net Shares Issued and Repurchased was $2.0 million for Q1 2026 at Revolution Medicines, down from $5.4 million in the prior quarter.
  • The five-year high for Net Shares Issued and Repurchased was $5.4 million in Q4 2025, with the low at $2.0 million in Q1 2026.
  • Average Net Shares Issued and Repurchased over 5 years is $3.1 million, with a median of $2.9 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2026: Net Shares Issued and Repurchased surged 104.08% in 2022, then sank 31.72% in 2026.
  • Over 5 years, Net Shares Issued and Repurchased stood at $2.8 million in 2022, then jumped by 32.68% to $3.7 million in 2023, then increased by 13.94% to $4.2 million in 2024, then gained by 29.58% to $5.4 million in 2025, then plunged by 63.88% to $2.0 million in 2026.
  • The last three Net Shares Issued and Repurchased figures came in at $2.0 million (Q1 2026), $5.4 million (Q4 2025), and $2.9 million (Q1 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn -
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn -
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn -
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn -3.07 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn -
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn -
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn -
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn -
10 Revolution Medicines 40.86 Bn 40.86 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.95 Mn
Dec 31, 2025 5.40 Mn
Mar 31, 2025 2.86 Mn
Dec 31, 2024 4.17 Mn
Mar 31, 2024 2.86 Mn
Dec 31, 2023 3.66 Mn
Mar 31, 2023 2.27 Mn
Dec 31, 2022 2.76 Mn
Mar 31, 2022 1.95 Mn
Dec 31, 2021 1.56 Mn
Mar 31, 2021 957,159.00
Dec 31, 2020 967,874.00
Mar 31, 2020 661,122.00
Dec 31, 2019 3.52 Mn
API Access

Revolution Medicines Net Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-shares-issued-and-repurchased&ticker=RVMD&period=max&api_key=YOUR_API_KEY